Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Novel BRCA1 deleterious mutation (c.1949_1950delTA) in a woman of Senegalese descent with triple-negative early-onset breast cancer.

Diez O, Pelegrí A, Gadea N, Gutiérrez-Enríquez S, Masas M, Tenés A, Bosch N, Balmaña J, Graña B.

Oncol Lett. 2011 Nov;2(6):1287-1289. Epub 2011 Aug 19.

2.

Identification of a new complex deleterious mutation in exon 18 of the BRCA2 gene in a hereditary male/female breast cancer family.

Diez O, Gutiérrez-Enríquez S, Masas M, Tenés A, Yagüe C, Arcusa A, Llort G.

Breast Cancer Res Treat. 2010 Sep;123(2):587-90. doi: 10.1007/s10549-010-0830-2. Epub 2010 Mar 16.

PMID:
20232139
3.

[Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].

Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, Shao ZM.

Zhonghua Yi Xue Za Zhi. 2005 Nov 16;85(43):3030-4. Chinese.

PMID:
16324400
4.

Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.

Patmasiriwat P, Bhothisuwan K, Sinilnikova OM, Chopin S, Methakijvaroon S, Badzioch M, Padungsutt P, Vattanaviboon P, Vattanasapt V, Szabo C, Saunders GF, Goldgar D, Lenoir GM.

Hum Mutat. 2002 Sep;20(3):230.

PMID:
12203997
5.

A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history.

Pisanò M, Mezzolla V, Galante MM, Alemanno G, Manca C, Lorusso V, Malvasi A, Tinelli A.

Fam Cancer. 2011 Mar;10(1):65-71. doi: 10.1007/s10689-010-9389-7.

PMID:
20878484
6.

BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.

Capalbo C, Ricevuto E, Vestri A, Ristori E, Sidoni T, Buffone O, Adamo B, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G.

Ann Oncol. 2006 Jun;17 Suppl 7:vii34-40.

7.

Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia.

Troudi W, Uhrhammer N, Sibille C, Dahan C, Mahfoudh W, Bouchlaka Souissi C, Jalabert T, Chouchane L, Bignon YJ, Ben Ayed F, Ben Ammar Elgaaied A.

J Hum Genet. 2007;52(11):915-20. Epub 2007 Oct 9.

PMID:
17922257
8.

Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.

Thirthagiri E, Lee SY, Kang P, Lee DS, Toh GT, Selamat S, Yoon SY, Taib NA, Thong MK, Yip CH, Teo SH.

Breast Cancer Res. 2008;10(4):R59. doi: 10.1186/bcr2118. Epub 2008 Jul 16.

9.

Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.

Valarmathi MT, Sawhney M, Deo SS, Shukla NK, Das SN.

Hum Mutat. 2004 Feb;23(2):205.

PMID:
14722926
10.

Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations.

Steffensen AY, Jønson L, Ejlertsen B, Gerdes AM, Nielsen FC, Hansen TV.

Fam Cancer. 2010 Sep;9(3):283-7. doi: 10.1007/s10689-010-9345-6.

11.

Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany.

Hamann U, Liu X, Bungardt N, Ulmer HU, Bastert G, Sinn HP.

Eur J Hum Genet. 2003 Jun;11(6):464-7.

12.

Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2.

Claes K, Poppe B, Machackova E, Coene I, Foretova L, De Paepe A, Messiaen L.

Genes Chromosomes Cancer. 2003 Jul;37(3):314-20.

PMID:
12759930
13.

BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients.

Garvin AM, Attenhofer-Haner M, Scott RJ.

J Med Genet. 1997 Dec;34(12):990-5.

14.

BRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South India.

Rajkumar T, Soumittra N, Nancy NK, Swaminathan R, Sridevi V, Shanta V.

Asian Pac J Cancer Prev. 2003 Jul-Sep;4(3):203-8.

15.

Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer.

Gao Q, Tomlinson G, Das S, Cummings S, Sveen L, Fackenthal J, Schumm P, Olopade OI.

Hum Genet. 2000 Aug;107(2):186-91. Erratum in: Hum Genet 2001 Aug;109(2):239-40.

PMID:
11030417
16.

[BRCA1 and BRCA2 gene mutations of familial breast cancer from Shanghai in China].

Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, Shao ZM.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Feb;23(1):27-31. Chinese.

PMID:
16456781
17.

Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.

Håkansson S, Johannsson O, Johansson U, Sellberg G, Loman N, Gerdes AM, Holmberg E, Dahl N, Pandis N, Kristoffersson U, Olsson H, Borg A.

Am J Hum Genet. 1997 May;60(5):1068-78.

18.

BRCA1 and BRCA2 mutations in a study of African American breast cancer patients.

Pal T, Permuth-Wey J, Holtje T, Sutphen R.

Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1794-9.

19.

Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history.

Dufloth RM, Carvalho S, Heinrich JK, Shinzato JY, dos Santos CC, Zeferino LC, Schmitt F.

Sao Paulo Med J. 2005 Jul 7;123(4):192-7.

20.

Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus.

Loizidou M, Marcou Y, Anastasiadou V, Newbold R, Hadjisavvas A, Kyriacou K.

Clin Genet. 2007 Feb;71(2):165-70.

PMID:
17250666
Items per page

Supplemental Content

Write to the Help Desk